Forward progress FDA Peptide Reclassification 2026: What Researchers Want Save Peptides Save Peptides The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them FDA mulls compounding for peptides previously flagged over safety risks BioSpace BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification